Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Viemed Healthcare, Inc. (VMD) had Revenue of $224.26M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$224.26M
Net Income	$11.27M
Cost of Goods Sold	$91.05M
Gross Profit	$133.20M
Operating Expenses	$208.09M
Operating Income	$16.17M
Non-Operating Income/Expense	$0.00M
Pre-Tax Income	$16.17M
Normalized Pre-Tax Income	$14.27M
Income after Taxes	$11.41M
Income from Continuous Operations	$11.41M
Consolidated Net Income/Loss	$11.41M
Normalized Income after Taxes	$8.94M
EBIT	$16.17M
EBITDA	$41.72M
Weighted-Average Shares Outstanding (Basic)	37.76M
Weighted-Average Shares Outstanding (Diluted)	40.80M
Earnings per Share (EPS) (Basic)	$0.29
Earnings per Share (EPS) (Diluted)	$0.28
Balance Sheet Financials
Current Assets	$52.88M
Property, Plant, and Equipment	$76.28M
Long-Term Assets	$124.19M
Total Assets	$177.07M
Current Liabilities	$37.33M
Long-Term Debt	$3.59M
Long-Term Liabilities	$6.44M
Total Liabilities	$43.77M
Common Equity	$133.30M
Tangible Shareholders Equity	$99.46M
Shareholders Equity	$133.30M
Common Shares Outstanding	39.13M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$39.09M
Cash Flow from Investing Activities	$-30.70M
Cash Flow from Financial Activities	$-3.69M
Beginning Cash	$12.84M
End Cash	$17.54M
Increase/Decrease in Cash	$4.70M
Stock-Based Compensation	$6.29M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.42
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.03
Gross Margin	59.40%
Operating Margin	7.21%
EBIT Margin	7.21%
EBITDA Margin	18.61%
Pre-Tax Profit Margin	7.21%
Profit Margin	5.02%
Free Cash Flow	$11.64M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.27
Inventory Turnover	21.08
Receiveable Turnover	9.00
Days Sales in Receivables	40.55
Return on Equity	8.56%
Return on Tangible Equity	11.47%
Return on Assets	6.44%
Return on Investments	8.33%
Book Value Per Share	$3.41
Free Cash Flow per Share	$0.29
Operating Cash Flow per Share	$0.96

Data from Zacks Investment Research, Inc.